Explore by health topic
View allGLP-1
Semaglutide, tirzepatide, retatrutide, side effects, dosing, and access.
Peptides
Recovery, metabolism, skin health, and evidence-based peptide guides.
Drug Guides
Plain-language coverage of major GLP-1 medications and comparisons.
Diet & Side Effects
Food, protein, fiber, nausea, fatigue, reflux, and long-term routines.
Latest
New guides from Middleway
Peptides
Semax Side Effects: Headache, Nasal Irritation and Dose Related Problems
Semax is generally well tolerated, but headache and nasal irritation are common enough to plan around, and long term safety data does not exist.
Peptides
Semax Review: Reported Results, Real Limits and Who It Suits
An assessment rather than a recommendation: what people consistently report, what the evidence supports, what it costs, and the reasons to skip it.
Peptides
NAD+ Injections: Dosage Ranges, Reported Effects and the Evidence Gap
Injecting NAD+ solves the absorption problem that limits oral use. What it does not solve is the absence of controlled evidence for what the injection achieves.
GLP-1
Mounjaro Injection: How to Do It, Where, and What to Avoid
A practical walkthrough of the Mounjaro pen: the three approved sites, the two clicks that matter, missed dose rules, storage limits and the common mistakes.
GLP-1
Mazdutide: The Trial Results, the Mechanism and the Access Problem
Mazdutide is a GLP-1 and glucagon dual agonist approved in China. The phase 3 results, how it differs from semaglutide and tirzepatide, and why access outside China is limited.
Peptides
Epithalon Side Effects: The Short List and the Telomerase Concern
Reported reactions are minimal, which is either reassuring or uninformative depending on how you read it. The telomerase question deserves a proper answer.
Peptides
Bioregulator Peptides for Aging: What They Are and What the Evidence Supports
Ultra-short peptides said to switch tissue-specific genes back toward a younger pattern. The theory is interesting. The independent evidence is the problem.
Peptides
Antimicrobial Peptides LL-37 & KPV: Mechanisms, Evidence and Cautions
LL-37 kills microbes and modulates immunity. KPV suppresses inflammation. They are often sold together and they do close to opposite things in the body.
Peptides
ACE-031 vs Apitegromab: Why Selectivity Decided Which One Survived
Two drugs aimed at the same pathway with opposite outcomes. The difference was not potency, it was how much else each one blocked along the way.